NSG 6005 Week 1 Quiz

NSG 6005 Week 1 Quiz Advanced Pharmacology Week 1 Pharmacodynamics  State control of prescriptive privilege is dependent authority  Barriers to practice for nurses in the diagnosing/prescribing role: o Regulatory irregularity (Florida) o Growing number of NPs without prior nursing experience  Clinical trials: o Phase 1 – initial eval that focuses on aborption, distribution, metabolism, and elimination – healthy people only o Phase 2 – tested in people with the disease o Phase 3 – FDA determines no serious adverse effects. Double blind research and data collection. Drug is compared to drug already used. FDA accepts or rejects. o Phase 4 – drug on market and monitoring happens. Adverse reactions are reported and checked out.  A prescription is a written, verbal, or electronic order from a provider or designated agent to a pharmacist for a particular med for a specific patient.  Pharmacokinetics o Absorption (how much is there and how fast it leaves site of admin) o What affects absorption? Characteristics, preparation, enteral and parenteral absorption, GI motility, Blood Flow, Cell Characteristics o p. 18 Passive diffusion = transfer through partially permeable barrier, smaller molecules are able to diffuse easier than larger. Molecular weights of 500 diffuse easily. 5000 do no